Trending News
News
News
PerkinElmer and JMC Collaborate to Develop Molecular Diagnostics Screening Platforms
Partnership expected to advance capabilities in screening assays and discovery and validation of new biomarkers.
News
Upstream Completes Acquisition of Genetic Diagnostic Marker Company
As a result of the transaction, Upstream Canada is now a wholly-owned subsidiary of the Company.
News
Shimadzu, Toppan and Third Wave Sign Agreement for Point-of-Care Instrument
The instrument is designed to analyzing a patient's DNA for specific gene sequences.
News
Xenomics Appoints New CEO
Dr. L. David Tomei has been appointed as new CEO.
News
Ipsogen Presents Breast Cancer Biomarker Results at the EBCC 5
These results concern the identification on 323 patient samples.
News
Brain Cancer Patients Living Longer After Personalized Vaccine Therapy
Patients are surviving twice as long with DCVax®-Brain as with other therapeutics.
News
Ark’s Platform Increases Efficacy of Anti-cancer Therapies
Gene-based drug targeting platform technology, has been shown to be effective in stopping tumour development.
News
Monogram and Dana-Farber Cancer Institute Enter Collaboration Agreement
The Institute will use Monogram's eTag™ technology in preclinical and clinical oncology research studies.
News
Transgenomic's Technology Used to Detect Mutations in EGFR Gene
The presence of EGFR mutations has been shown to correlate with response to targeted therapeutics that inhibits EGFR.
News
LabCorp® Licenses the Seryx Pharmacogenetic Interpretation and Reporting Service
Proprietary service helps physicians use CYP450 information to customize medications for optimal patient treatment.
Advertisement
